Central nervous system (CNS) involvement is a critical prognostic factor for hemophagocytic lymphohistiocytosis

Abstract

CNS involvement is common among patients with HLH. Overall, patients with CNS disease achieve poorer outcomes than patients without CNS involvement. To improve outcomes, physicians must carefully monitor the neurological manifestations in patients with HLH and administer the appropriate course of intensified chemotherapy to patients with CNS disease.